Windward Bio Group AG (WWB)
null: WWB · Real-Time Price · USD
24.29
+0.27 (1.15%)
At close: Nov 20, 2026, 4:00 PM EST
24.31
+0.02 (0.10%)
After-hours: Nov 20, 2026, 7:30 PM EST
Windward Bio Group AG Market Cap
Windward Bio Group AG has a market cap or net worth of $1.41 billion as of November 20, 2026. It is the 7,777th most valuable company in the world and the 1,930th biggest in the United States.
Market Cap
1.41B
Enterprise Value
1.22B
1-Year Change
n/a
Global Rank
Country Rank
#1,930 United States
Category
ChartMarket Cap Chart
Since the IPO on November 13, 2026, Windward Bio Group AG's market cap has increased from $986.66M to $1.41B, an increase of 42.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.41B | 1.15% |
| Nov 19, 2026 | 1.39B | 6.05% |
| Nov 18, 2026 | 1.31B | -12.11% |
| Nov 17, 2026 | 1.50B | -14.25% |
| Nov 16, 2026 | 1.74B | 5.40% |
| Nov 13, 2026 (IPO Date) | 1.65B | 67.65% |
| Nov 12, 2026 (IPO Priced) | 986.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.38B |
| Tyra Biosciences | 1.36B |
| Nuvation Bio | 1.34B |
| Generate Biomedicines | 1.33B |
| Innoviva | 1.31B |
| Intellia Therapeutics | 1.30B |
| LB Pharmaceuticals | 1.29B |
| MannKind | 1.29B |